Introduction and hypothesis Although in-depth qualitative information is critical to understanding patients' symptom experiences and to developing patient-centered outcome measures, only one previous qualitative study has assessed urological chronic pelvic pain syndrome (UCPPS) symptom exacerbations ("flares").
Introduction
Female urological chronic pelvic pain syndrome (UCPPS, or interstitial cystitis/bladder pain syndrome [IC/BPS]) is a common condition characterized by pain, pressure, or discomfort perceived to be related to the bladder, and lower urinary tract symptoms, such as urinary urgency and frequency, of at least 6 weeks' duration, in the absence of infection or other identifiable causes [1] . It affects 1-7 % of women in the USA [2, 3] and there is no cure or consistently effective therapy [4] .
Although the natural history of UCPPS is widely believed to include symptom exacerbation ("flares") and remission, few studies have described or defined exacerbation [5] [6] [7] [8] [9] [10] , and only one previous qualitative study, to our knowledge, has explored flares from the patient's perspective [11] . The importance of this question was highlighted recently in a small longitudinal study of flares, in which some participants reported flares lasting only a few minutes [8] -a shorter duration of flare than had been documented previously in the literature [5, 7, 10] and one that we have since found to be fairly common (30 % of female participants reported experiencing flares lasting minutes in response to a short survey [9] ). This unexpected finding raised the possibility of other, less well-recognized aspects of flares. Additionally, only a few previous studies have examined patient-reported triggers and self-care strategies for flares [11] [12] [13] [14] [15] , and only one study-our previous survey-has explored the impact of flares on patients' lives [9] . Although we found that both flare duration and pain severity influenced the degree of flare-related disruption and bother in that study [9] , we did not examine the specific impact of flares on patients' lives (e.g., impact on work and relationships). Therefore, to explore this impact further and to examine the full spectrum of flares, and their associated triggers and treatment, we conducted focus groups of UCPPS participants in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. This type of formative, in-depth, qualitative research is critical to informing the development of patient-centered outcome measures for use in future studies of UCPPS flare etiology, treatment, and management.
Materials and methods

Study design and population
The MAPP Research Network's central protocol, the MAPP Epidemiology and Phenotyping (EP) Study [16] , is a longitudinal, observational study of the treated natural history of UCPPS. In the MAPP Network, the phrase "treated natural history" is used to refer to the clinical course of patients observed over time while receiving standard care, and the term "UCPPS" is used to encompass IC/BPS in men and women, and chronic prostatitis/chronic pelvic pain syndrome in men. Eligibility criteria for female MAPP participants include a diagnosis of IC/BPS, age ≥18 years, and a nonzero score for bladder and/or pelvic pain, pressure, or discomfort in the past 2 weeks.
For the present study, we conducted eight focus groups of female UCPPS patients, two each at four participating Discovery Sites of the MAPP Research Network. Each of these sites was asked to recruit one group of participants enrolled in the MAPP EP study ("MAPP") and one group who would otherwise qualify for the EP study, but who were not participants in this protocol ("MAPP-naïve"). We chose to conduct MAPP focus groups to contextualize flare-related findings in the parent MAPP study and for practical reasons, i.e., to ensure sufficient focus groups to achieve saturation within the time frame of the study. We chose to conduct MAPP-naïve focus groups to avoid any possible influence that participation in the EP study might have on participants' responses, as some EP questionnaires refer to the term "flare" and assess possible flare triggers. Focus groups were conducted from April through June 2012. All participants provided informed consent and the focus group protocol was approved by the institutional review board at each participating site.
Study procedures
Each focus group consisted of a 1.5-h moderator-directed discussion (for an example of the moderator's guide, see Table 7 in the Appendix) and all were facilitated by the same female moderator. Following the discussion, participants were asked to complete five brief questionnaires similar to those used in the EP study. These included a demographics survey, a medical history survey, the IC Symptom Index and Problem Index [17] , the female Genitourinary Pain Index [18] , and a general symptom survey that included questions on whether or not participants were currently experiencing a "flare," defined as urological or pelvic pain symptoms that are "much worse than usual," and the number of flares experienced in the past year [16] . All focus groups were recorded and transcribed verbatim by trained transcriptionists, and transcripts were checked for accuracy and de-identified.
Qualitative analysis
After a review of all transcripts, we developed a comprehensive set of descriptive codes for qualitative analysis [19] . We developed most of these codes deductively from the moderator's guide and a few codes inductively based on a review of the transcripts. One primary rater coded all quotes, while a second rater coded approximately 20 % of the quotes (mean kappa for agreement across all codes=0.91; median=1.00). We used Atlas-ti software (version 7) to facilitate the qualitative analysis.
Results
Fifty-seven (34 MAPP and 23 MAPP-naïve) patients participated in the eight focus groups (mean=7/group). Participants ranged in age from 19 to 77 years (mean=44), were mainly Caucasian (91.2 %), and reported having experienced UCPPS symptoms for 1-45 years (mean=12; Table 1 ). Participants' mean symptom ratings in the past 2 weeks were 4.0 (on a scale 
Flare description
Almost all participants, even the few with relatively constant severe symptoms, reported periods of time when their symptoms were worse. Most participants referred to these periods of time as "flares" or derivations thereof (e.g., "flare-ups," "flare-outs," or "flaring days"), whereas a smaller number referred to them as "bad days," "bad bladder days," "stay-inbed days," or "episodes." These names did not vary by MAPP/MAPP-naïve status. Irrespective of the term used, symptom exacerbations encompassed a wide spectrum of experiences, ranging from small increases in symptoms that interfered with participants' thoughts ("If I even think about it or notice it, I consider it a flare") to large increases in symptoms that prevented them from carrying out their usual activities or incapacitated them ("When I consider myself having a flare, it's when I'm in bed all day, and where I can't move"). Most participants described flares at the more severe end of the spectrum, whereas fewer described mild flares unless specifically asked by the moderator. Two participants also mentioned "spasms"; one described them separately from flares and with milder symptoms ("A feeling like [squeezing] in my bladder" with increased urinary frequency), and the other described them with more severe symptoms ("A Charlie horse, but it's in your bladder" that caused the participant to drop to the floor).
Flares at the milder end of the spectrum, which participants sometimes referred to as "minor" or "moderate" flares (Table 2) , were described as a slight increase in pain, pressure, discomfort, sensitivity, throbbing, or burning with urination, and/or a large increase in urinary frequency. These flares lasted for hours to weeks and could occur anywhere from once/month to once/3 months. Their onset was typically gradual with symptoms increasing over the course of a day or fromFlare treatments and self-management strategies When participants knowingly engaged in/consumed flare triggers, they sometimes reported strategies to minimize or prevent their flares (Table 3) , which were especially important for behaviors such as sexual activity to help maintain their romantic relationships. Participants also reported a variety of different ways in which they managed their flares once they had begun, typically starting with the least potent therapies and only progressing to more potent therapies (e.g., opiates/opioids, medications with greater side-effects, medical procedures, and emergency room visits) for more severe, recalcitrant flares (see Table 4 for a full list of treatments/selfmanagement strategies). Participants also expressed an interest in ready or same-day access to non-emergency medical care during flares. Finally, beyond the immediate therapeutic effect of flare management strategies, a few participants reported that certain medications/ therapies had reduced the overall severity and/or frequency of their flares (e.g., birth control, pentosan polysulfate sodium [Elmiron®, Janssen Pharmaceuticals, Beerse, Belgium], bladder instillations, hydrodistension, and physical therapy). "I could be fine and just be standing there and it drops me to my knees the pain is so severe. And then I'm fine. I mean it lasts maybe three minutes and then I'm completely fine." "I get them usually at night and I just go sit on the toilet, pillow in the sink. I try to drink more water, but never emptying your bladder and it just burns and burns and the pain is just awful." Symptom exacerbation names "Mild," "moderate," "minor," "mini,"
"light," "tiny," or "little" flare "Severe," "major," "grand," "big," "huge," "bad," or "serious" flare Symptoms, symptom severity, and symptom descriptors Sensitivity "A little more sensitive" " Particularly sensitive"
Pressure "Dull pressure"; "constant pressure" " A lot of pressure"; feels like "carrying cantaloupes" Discomfort "A little more uncomfortable" Not mentioned Pelvic pain Level "A little bit of pain"; "just noticeable but there" "Crippling pain all the time"; pain "through the roof"
1-4 on a scale of 0-10 6 through 15 on a scale of 0-10 Description "Ache and pain" " Burning hot core of throbbing pain"; "intense searing pain"
UTI-like feelings "Very dull UTI coming on" " Searing UTI pain"
Pain related to urination "Burning in the urethra" during voiding "Feels like I'm urinating razor blades" Urgency Not mentioned "Intense urgency" Patient-reported triggers are listed in the approximate order of frequency with which they were brought up in the focus groups, with those discussed with the greatest frequency listed first and those discussed with the lowest frequency listed last
Immediate impact of flares
Irrespective of the severity of their symptoms, most participants reported some immediate impact of flares, including irritability, anxiety, and a reduced ability to concentrate (see Table 5 for a full list and representative quotes). Increased urinary frequency also forced many participants to remain close to a restroom, and could be disruptive and contributed further to anxiety for participants in jobs/situations with less flexibility. Additional influences of flares were determined largely by their severity and duration. For milder flares with less pain, participants were able to continue their regular activities and even reported that these activities provided a good distraction from their symptoms. In contrast, for flares with more severe pain, participants reported having difficulty standing ("dropping to the floor" with pain) or even moving, which forced many to stay in bed or the restroom for the duration of their flare. Consequently, many participants had to cancel social plans; stop work, which could be disruptive even for brief flares if they occurred in structured situations (e.g., on a factory line); and a few had to go to the emergency room during long flares. Finally, pain medications also contributed to the impact of flares, as some caused extreme drowsiness or dizziness.
Beyond the physical impact of severe flares, participants also reported a mental and emotional impact of these flares, particularly if they had not had a flare in a while and believed their condition to be improving. They reported going back into "fear mode," feeling "demoralized," and some reported having difficulty envisioning their future with a cycle of severe pain. They also reported an emotional impact of flares on their spouses and family members that, in turn, made them feel badly and added to their level of stress.
Long-term impact of flares
For some participants, flares did not have a major reported long-term impact beyond such things as travelrelated or general anxiety, and various changes to their daily routines for flare prevention (see Table 6 for representative quotes). These included eliminating certain foods/beverages from their diet, reducing their frequency of sexual activity, and generally reducing their degree of spontaneity. For other participants, however, these changes were more dramatic. For instance, some stopped or greatly reduced travel, some eliminated a large number of foods from their diet, and some greatly reduced the frequency of sexual activity. Even participants who did not report a major impact of flares described a constant awareness or vigilance for things that might trigger a flare, and an attempt to control these factors. One participant even reported that the stress of worrying about a flare could trigger its occurrence.
While not stated explicitly, this degree of lifestyle change and vigilance appeared to influence participants' level of social interaction. For instance, they reported making fewer social plans out of concern that they might coincide with a future flare, and staying home more to relax and reduce their levels of stress. Major reductions in sexual activity also had an impact on participants' social interactions, as some participants, particularly younger ones, reported a lack of desire to initiate new sexual relationships, and some reported marital or relationship strain. With regard to their work and school life, a few participants who experienced frequent, severe flares reported losing their jobs because of flares, some went on disability leave or became self-employed to accommodate flares, and some had difficulty completing their education. Finally, participants reported that flares contributed to general anxiety, which a few addressed by carrying flare medications or self-care products with them at all times, and at their worst, a few participants reported that flares had "ruined" their lives. Irritability "I'm probably a total bitch to everyone that sees me."
Anxiety "I become very anxious, if I have to teach a class and I have the symptoms, because I know that I can't stop in the middle and run out to the restroom." Reduced ability to concentrate "And I can't focus on my finals. And I usually end up getting bad grades because I'm so focused on I need to get out of here." Difficulty wearing certain types of clothing "I've noticed that a lot of times it's made worse by like physical conditions. Like tight clothes, pads." Lack of desire to engage in sexual activity "There's definitely we're not having sex tonight, so it interferes in that way."
Desire or need to be close to a bathroom "I sit at home all day. I'm scared to leave the house. I don't know how bad it's going to get, if it's going to get worse." Difficulty standing or moving, forcing participants to rest or stay in bed or the restroom "But when I'm in a flare-up I can't walk across campus. I can get everywhere on campus within 10 to 15 min, but that is a really long time when you are in so much pain you can barely get out of bed in the morning." Cancelling social events "There are things like I've had to miss out on though. Like friends' birthdays and stuff where I've been like, I can't go. I cannot physically go." Stopping or missing work or school "If it gets really, really bad, I do have to stop work, because I just can't be working and constantly in the bathroom, and bent over in pain." Going to the emergency room "And then if Vicodin's not working then I add on all these other things…and then the times when those haven't worked, I've gone to the ER." Going on family and medical leave "I was in a trial for medication and it flared me, and I was sick for two years. I was on FMLA at that point." Drowsiness or dizziness from pain medications "I get all like light-headed and like you know, like dizzy and like high-feeling from the Vicodin…So I have to like really plan like if I think I'm going to have a flare, I need to like plan for school."
Emotional impact of flares on patients "I also have that feeling of helplessness, hopelessness and feeling like is this ever going to get better, is there ever going to be a day when I don't have to deal with this and at its worst, I've just started to think, is this something I can live with the rest of my life?…But I know that it's happened before and I've survived and I've moved on, but when it happens again that intensely, it's just completely discouraging. Because sometimes I'll think for months on end, I'll be pretty stable in my symptoms and I think I'm better, but then when that major flare-up hits, it makes me realize that that's not the case…so very demoralizing." P: "We all have our moderate tone that we live on, but when things really kind of [freak] out, and it flares, you're like, oh, my god, is this it? Am I going to pull out of this one?…Then you're dealing with some forms of depression, and then you have anxiety…" M: "So let me see a show of hands around the table for how many people feel that this resonates with them, that they are…so almost everybody." Emotional impact of flares on patients' spouses and family members "The kids know…that I'm crabby and that I'm depressed. And so everyone in my family [has] to walk around on eggshells." "So for me that's the worst part, the anxiety and feeling bad, because I know my husband will feel so bad for me and then I'll feel guilty." "it's like I do laundry for four people and my underclothes have to have this whole special process, so it's just incredibly inconvenient." Diet "I try to avoid a lot of sugar and processed foods, and I rarely eat out anyway."
"My life is extremely rigidly controlled. I don't eat any flour…I don't eat anything with corn syrup. I don't do any dairy in any way, shape, or form. And when I mean flour, I don't even do tomato soup, because the third ingredient is whole wheat flour." Physical activity "Well, you know, I used to exercise a lot, and now, I don't. Now I go for nice, like, strolls in the woods."
"I can no longer play softball. I can no longer run.
[They] told me I couldn't even go for long walks." Sexual activity "Frequency of sex is definitely different." " I've been married to my husband for 11 years. And, you know, once it started it was like that was it…It's, like, having a relationship with someone that you love so much, and you can't be sexual with them, because it's that painful." Reduced spontaneity "That's what I miss most, I think, being able to just get in the car and go and not have to worry."
"it does make everything so much more of a challenge. Impact of flare-related changes and other impact of flares Reduced social interaction "As far as relations, I don't have a lot of people around me that…well, I don't want to have anybody around me worrying about me or anything, but I also keep people out, because I don't want to be stressed. Like, I can't have somebody wanting something from me or, you know, other people's needs. So it's made me a little bit of a recluse." "I hate going out to eat, and I hate going to people's houses, because no matter how many times I'll try to explain it, my mom doesn't get the diet that I, you know, sometimes have to be on more than other times." "I used to always go with my friends, but now I cancel. I had to cancel all the time. Couple of my friends just dropped me. They don't even ask me to do anything. I lost a lot of friends." Romantic relationship avoidance and strain "I won't date because I don't want anybody near me. I'm scared that it'll hurt if I try and do anything, so I don't." "And he doesn't want to hurt me and it's a real difficult situation…thank God we love each other so much, but it has been an issue. It'll continue to be an issue, I think." Reduced career or educational advancement "Thinking about going back to school, which I would like to be a nurse anesthetist, but thinking of my career and being in the OR and not being able to leave, thinking about career changes because of it." "it has made me, for sure, stay at a certain level of poverty, because there's no way I can work eight hours. And I'm self-employed because of that too. I stay self-employed, because I have to have a job where if I don't feel good, you know, I can't lose everything." "I haven't been able to work for over a year. I'm only 20 years old-I should be able to do that. I haven't been in college for two years." "Ruined life" P1: "It ruins your life." P2: "It has ruined my life." Additional impact of flares and UCPPS in general "I started retaining a lot of water when I was doing the drug therapy and so bad I gained 40 lb in just water weight."
During our discussion about the impact of flares on participants' lives, we attempted to distinguish the impact of flares from that of UCPPS in general. Some participants were able to distinguish the two clearly and their responses are described above:
"At its normal level, I can function. But because of the flares I can't make certain plans. Like, I can't be too [ambitious]…I just live a much more quiet [simple] life." For other participants, however, it was not possible to distinguish the impact of flares from that of their basic condition. In general, the reported impact of UCPPS was similar to that of flares, although it tended to be more closely related to urinary frequency and the desire to remain close to restrooms (e.g., avoiding activities with less easy access to restrooms) than to pain or the fear of pain during flares. They also mentioned additional broader consequences of flares or their condition, such as medication-related weight gain, becoming confined to their homes, losing touch with family members, getting divorced, and becoming depressed (see Table 6 for a full list and representative quotes). Finally, a recurrent theme for participants was that UCPPS is life-changing, and affects all aspects of their lives and everyone close to them.
Discussion
In our focus groups of female UCPPS patients, we identified a wide spectrum of symptom exacerbations described by most participants as "flares." These flares ranged from mild, uncomfortable symptoms that were short-lasting and interrupted participants' thoughts, to severe, painful symptoms that could last for as long as 2 years and prevented them from working or leaving their homes. Along this spectrum of flares, participants also reported variability in pelvic pain and urological symptoms involved (e.g., pain only, pain with urological symptoms, and occasionally urological symptoms only); nonpelvic or -urological symptoms (e.g., diarrhea); and frequency of flares (e.g., daily to less than once a year). Similar to findings from our previous survey, the most commonly reported flare experiences were painful flares that lasted for several days and were accompanied by urological symptoms (reported by 87 % of female participants in our previous survey [9] ). These flares also tended to be most disruptive for participants, although sudden, short painful flares and flares limited to increased urinary frequency could also be disruptive, particularly in structured situations.
Beyond their immediate, disruptive impact, flares also had a longer-term and broader impact on participants' lives, Weight gain from medications and less physical activity, and other side effects of medications "Part of my depression is because I've gained so much weight. I'll be looking back at pictures when I was in high school, and I was like 120-130 lb, and…they're like, 'Well, make sure you keep your physical activity.' Well, what physical activity do you want me to do?" "My antidepressant messed up my liver. So it's like okay, I don't have a perfect liver right now or a perfect kidney, but yet I won't die from this." Poor posture "It affects your posture…I don't stand up straight anymore."
Urinary tract analgesic agent staining "With the Pyridium I've stained somebody's toilet. And they're, like, 'Why is my toilet like an orangey-yellow color?' And I'm, like, 'I'm sorry, I'll come over and bleach it, but that was my urine.'" Home confinement "And I enjoyed being with people. Now I'm stuck in my house all day long, and it's really a horrible feeling."
"You're tired of looking at the four walls. You can't look at them walls, yeah. They start closing in on you."
Losing touch with family members "There are certain people-even people that are close to me like my father and my sister, in particular, they don't want to hear anything about it. They were with me for the first few years that were real bad and then they said, 'We can't take it anymore.' I guess sometimes you have to pick and choose. And sometimes those you think would be understanding won't necessarily be." Getting a divorce "I am going through a divorce, so I see it actually really affected our marriage, my husband couldn't stand it, couldn't deal with a chronic illness." Concerns for the future "But I've always been just really frightened of like, is my body going to be able to handle pregnancy? And then, yeah, if I ever want to be a particularly those that occurred frequently and/or were painful and long-lasting. Participants who experienced these types of flares reported difficulties completing their education, quitting or losing their jobs, relationship strain, and anxiety. Although these consequences are similar to those reported for UCPPS in general in both our study and the literature [13, [20] [21] [22] [23] [24] [25] [26] [27] [28] , some participants attributed these consequences directly to flares, suggesting that one useful way of improving their quality of life would be to identify approaches to preventing or treating their flares, or of reducing the severity, duration, and/or frequency of their flares (e.g., through the longer-term effects of medications). Together with findings on the immediate impact of flares and those from our previous survey [9] , these results also suggest that flare characteristics, such as symptom severity, duration, and frequency, and their degree of disruption or bother, should be taken into consideration when developing patient-centered outcome measures of flare burden. In addition to flare characteristics, the unpredictability of flares also contributed to their negative impact. This unpredictability made it difficult for participants to carry out their day-to-day activities, in addition to planning for and realizing longer-term goals. A recurrent theme for participants was thus the need for control over their symptoms, consistent with findings from a previous focus group study of goal achievement among female patients [29] . In our focus groups, the need for control frequently manifested as thorough selfreflection and the development of detailed narratives to explain their flares. While this process appeared to allow some participants to avoid or minimize their flares (e.g., ibuprofen before sexual activity) and provided others with a sense of control and a helpful coping mechanism, it was not clear for many other participants to what extent their personal hypotheses about flare triggers had a physiological basis or were helpful in controlling symptom variation. This retrospective flare trigger identification process also led many participants to lead highly restrictive lifestyles. Another way in which participants gained a sense of control over their symptoms was by carrying flare medications with them at all times or when they traveled, or by having ready access to health professionals. Either way, having a sense of control over some aspect of their flares seemed to be an important coping mechanism for participants. Therefore, helping patients understand how to assess their triggers correctly and giving them meaningful reassurance that they have access to treatment during flares (e.g., by discussing a flare strategy with patients) may help them to lead more active and satisfying lives.
In addition to control, another cross-cutting theme identified in the focus groups was reduced social engagement. While several studies have noted a lesser degree of social functioning or support in patients than in healthy women [22, 23, [30] [31] [32] , few have described the causes or consequences of this reduced functioning [26] . We found that, during flares, participants reported cancelling family and social activities, missing work or school, and preferring to stay home to be close to a bathroom. When not experiencing a flare, they also reported avoiding making social and travel plans out of fear that a flare might occur and because of nonflare-related urinary frequency; avoiding activities that involved food prepared by others to reduce accidental exposure to flare triggers; reducing their physical activity, including playing team sports; avoiding romantic relationships; and staying at home and "withdrawing" from life to avoid the stress of interacting with other people and life in general. Some participants also reported losing friends because of cancellations, and losing family and/or spouses because of the difficulties of interacting with patients with chronic, debilitating conditions, and because of diminished levels of sexual activity. Many were not happy with their reduced degree of social interaction, and reported that lying in bed or sitting at home contributed further to their depressed mood. Therefore, finding ways in which to increase patients' degree of social engagement-for instance, by in-person or online support groups, by better flare trigger identification to avoid unnecessary social restrictions, or by lay health advisors/companions-may serve to reduce the negative impact of UCPPS on patients' lives and to relieve some of the burden on their family members and spouses.
A few further novel observations also deserve mention. With regard to flare symptoms, nonpelvic symptoms, such as diarrhea and exacerbated IBS or fibromyalgia symptoms, have not, to our knowledge, been described and could be explored further for their possible insight into systemic processes. Newly reported flare triggers, including dehydration, brands of toilet paper, brands of water or water of varying pH, PAP smears, forgetting to take medications, skipping meals, and emotions, could also be incorporated into future research efforts. Finally, additional reported consequences of flares and UCPPS (e.g., staining toilets by urine colored by urinary tract analgesic agents, weight gain from reduced physical activity and the side effects of medications, and poor posture from chronic pain) may warrant further research attention to help to improve patient quality of life.
As a final consideration, our results illustrate a range of experiences reported by participants during a directed group discussion and should be interpreted as such. They cannot be used to quantify participants' experiences or to represent experiences of participants with different characteristics than those who participated in our focus groups-primarily patients from specialized urological and gynecological centers. Having said that, a recent comparison of patients from these same types of centers with a community-based sample of symptomatic women found generally similar levels of symptoms [33] , suggesting that our findings might be generalized to patients not receiving specialty care. Differences between MAPP and MAPP-naïve participants likely reflect differences in patients' interest and ability to participate in a complex and demanding study, such as MAPP.
In summary, we identified a wide spectrum of flare experiences and major immediate and long-term impacts of flares, particularly those that occur frequently, and are painful, long-lasting, and unpredictable. Therefore, we suggest that patient-centered outcome measures of flare burden should include flare characteristics, such as frequency, severity, duration, and predictability. Future research should focus on approaches to preventing flares (e.g., by trigger identification and therapy), to reducing their frequency, severity, and/or duration, and to reducing flare-related anxiety (e.g., by on-hand medications, same-day medical appointments, mindfulness meditation/stress reduction). Our findings also suggest that patients' quality of life might be improved by engaging them socially. a Our procedure was to first ask the question and encourage general discussion, and then to follow up with specific probes, as needed, to address additional aspects of the topic
